These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32830297)

  • 1. Optimizing Predictive Performance of Bayesian Forecasting for Vancomycin Concentration in Intensive Care Patients.
    Guo T; van Hest RM; Zwep LB; Roggeveen LF; Fleuren LM; Bosman RJ; van der Voort PHJ; Girbes ARJ; Mathot RAA; Elbers PWG; van Hasselt JGC
    Pharm Res; 2020 Aug; 37(9):171. PubMed ID: 32830297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
    Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
    Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population.
    Duong A; El Gamal A; Bilodeau V; Huot J; Delorme C; Poudrette J; Crevier B; Marsot A
    Pharmacotherapy; 2024 Jun; 44(6):425-434. PubMed ID: 38803279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Drug Monitoring Coupled With Bayesian Forecasting Could Prevent Vancomycin-Associated Nephrotoxicity in Renal Insufficiency Patients: A Prospective Study and Pharmacoeconomic Analysis.
    Zhang Y; Wang T; Zhang D; You H; Dong Y; Liu Y; Du Q; Sun D; Zhang T; Dong Y
    Ther Drug Monit; 2020 Aug; 42(4):600-609. PubMed ID: 32097248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients.
    Polard E; Le Bouquin V; Le Corre P; Kérebel C; Trout H; Feuillu A; Le Verge R; Mallédant Y
    Ther Drug Monit; 1999 Aug; 21(4):395-403. PubMed ID: 10442692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TDM coupled with Bayesian forecasting should be considered an invaluable tool for optimizing vancomycin daily exposure in unstable critically ill patients.
    Pea F; Bertolissi M; Di Silvestre A; Poz D; Giordano F; Furlanut M
    Int J Antimicrob Agents; 2002 Nov; 20(5):326-32. PubMed ID: 12431867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring of imatinib: Bayesian and alternative methods to predict trough levels.
    Gotta V; Widmer N; Montemurro M; Leyvraz S; Haouala A; Decosterd LA; Csajka C; Buclin T
    Clin Pharmacokinet; 2012 Mar; 51(3):187-201. PubMed ID: 22339450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Vancomycin Dose Individualization Strategy by Bayesian Prediction in Patients Receiving Continuous Renal Replacement Therapy.
    Oda K; Jono H; Kamohara H; Nishi K; Tanoue N; Saito H
    Pharm Res; 2020 May; 37(6):108. PubMed ID: 32468340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic external evaluation of reported population pharmacokinetic models of vancomycin in Chinese children and adolescents.
    Lv C; Lu J; Jing L; Liu TT; Chen M; Zhang R; Li C; Zhou S; Wei Y; Chen Y
    J Clin Pharm Ther; 2021 Jun; 46(3):820-831. PubMed ID: 33751618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated calculation and reporting of vancomycin area under the concentration-time curve: a simplified single-trough concentration-based equation approach.
    Kim H-K; Jeong T-D; Ji M; Kim S; Lee W; Chun S
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0069924. PubMed ID: 39194211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bayesian forecasting of plasma vancomycin concentration using time-dependent pharmacokinetics].
    Nakamura T; Wakaki N; Kimura Y; Goto N; Masada M
    Yakugaku Zasshi; 1996 Nov; 116(11):876-83. PubMed ID: 8981831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of predicting the vancomycin concentration in Japanese cancer patients by the Sawchuk-Zaske method or Bayesian method.
    Nakashima T; Ohno T; Koido K; Hashimoto H; Terakado H
    J Oncol Pharm Pract; 2020 Apr; 26(3):543-548. PubMed ID: 31142231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hybrid machine learning/pharmacokinetic approach outperforms maximum a posteriori Bayesian estimation by selectively flattening model priors.
    Hughes JH; Keizer RJ
    CPT Pharmacometrics Syst Pharmacol; 2021 Oct; 10(10):1150-1160. PubMed ID: 34270885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic modelling and Bayesian estimation-assisted decision tools to optimize vancomycin dosage in neonates: only one piece of the puzzle.
    Allegaert K; Flint R; Smits A
    Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):735-749. PubMed ID: 31402708
    [No Abstract]   [Full Text] [Related]  

  • 15. Why we should sample sparsely and aim for a higher target: Lessons from model-based therapeutic drug monitoring of vancomycin in intensive care patients.
    Guo T; van Hest RM; Fleuren LM; Roggeveen LF; Bosman RJ; van der Voort PHJ; Girbes ARJ; Mathot RAA; van Hasselt JGC; Elbers PWG
    Br J Clin Pharmacol; 2021 Mar; 87(3):1234-1242. PubMed ID: 32715505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the prediction accuracy of vancomycin concentrations determined by patient-specific parameters as estimated by Bayesian analysis.
    Hiraki Y; Onga T; Mizoguchi A; Tsuji Y
    J Clin Pharm Ther; 2010 Oct; 35(5):527-32. PubMed ID: 20831677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin pharmacokinetics and Bayesian estimation in pediatric patients.
    Wrishko RE; Levine M; Khoo D; Abbott P; Hamilton D
    Ther Drug Monit; 2000 Oct; 22(5):522-31. PubMed ID: 11034256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Performance of Bayesian Vancomycin Monitoring in the Critically Ill.
    Narayan SW; Thoma Y; Drennan PG; Yejin Kim H; Alffenaar JW; Van Hal S; Patanwala AE
    Crit Care Med; 2021 Oct; 49(10):e952-e960. PubMed ID: 33938713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian prediction-based individualized dosing of anti-methicillin-resistant Staphylococcus aureus treatment: Recent advancements and prospects in therapeutic drug monitoring.
    Oda K; Saito H; Jono H
    Pharmacol Ther; 2023 Jun; 246():108433. PubMed ID: 37149156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive performance of reported population pharmacokinetic models of vancomycin in Chinese adult patients.
    Deng C; Liu T; Wu K; Wang S; Li L; Lu H; Zhou T; Cheng D; Zhong X; Lu W
    J Clin Pharm Ther; 2013 Dec; 38(6):480-9. PubMed ID: 24033587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.